Author

William W. Hauswirth

University of FloridaORCID 0000-0002-3244-4947Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Sanford L. BoyeiD· 2 shared Alejandra BoscoiD· 1 shared Ana Ripolles‐GarciaiD· 1 shared Artur V. CideciyaniD· 1 shared Cesar O. Romero· 1 shared Gustavo David AguirreiD· 1 shared Kevin BreeniD· 1 shared Małgorzata Świder· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Sanford L. BoyeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene Therapy Reforms Photoreceptor Structure and Restores Vision in NPHP5-associated Leber Congenital Amaurosis

Gustavo David Aguirre, Artur V. Cideciyan, Valérie Dufour, Ana Ripolles‐Garcia, Raghavi Sudharsan, Małgorzata Świder, Roman Nikonov, Simone Iwabe, Sanford L. Boye, William W. Hauswirth, Samuel G. Jacobson, William A. Beltran

This paper demonstrates that gene therapy using AAV-mediated NPHP5 augmentation restores photoreceptor structure and function in a canine model of Leber congenital amaurosis.

Molecular Therapy · Mar 27, 2021Peer-reviewedNeuroscience

Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma

Alejandra Bosco, Sarah Anderson, Kevin Breen, Cesar O. Romero, Michael R. Steele, Vince A. Chiodo, Sanford L. Boye, William W. Hauswirth, Stephen Tomlinson, Monica L. Vetter

This study shows that targeting complement C3 with gene therapy reduces neurodegeneration in glaucoma by protecting retinal ganglion cells.

Molecular Therapy · Aug 23, 2018Peer-reviewedNeuroscience